Amy Amundson Smith MD
Pediatric Neuro-Oncology
Director, Pediatric Neuro-Oncology Cleveland Clinic Children’s Cleveland Clinic, Cleveland Ohio
Join to View Full Profile
9500 Euclid AveR3Cleveland, OH 44195
Phone+1 216-444-0663
Fax+1 321-841-8560
Dr. Smith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Amy Smith is a pediatric hematologist/oncologist with specialization in Neuro-Oncology at the Cleveland Clinic in Cleveland, OH. She received her medical degree from Medical College of Georgia School of Medicine and has been in practice 23 years. She has specialized expertise in pediatric neuro-oncology, clinical and translational research.
Education & Training
University of ColoradoFellowship, Pediatric Hematology/Oncology, 2000 - 2003- University of ColoradoResidency, Pediatrics, 1997 - 2000
Medical College of Georgia at Augusta UniversityClass of 1997
Certifications & Licensure
FL State Medical License 2003 - 2027
GA State Medical License 2025 - 2027
OH State Medical License 2025 - 2027
CO State Medical License 2000 - 2005
American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
- External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas Start of enrollment: 2009 Oct 30
- Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Start of enrollment: 2010 May 07
Publications & Presentations
PubMed
- PTPN11-related Noonan syndrome predisposes to multifocal low-grade CNS tumors harboring FGFR1 variants.Gary Kohanbash, Scott Ryall, Sam E Gary, Lindsey M Hoffman, Robert Siddaway
Journal of Neuro-Oncology. 2026-03-05 - Idasanutlin in Combination with Chemotherapy or Venetoclax in Pediatric and Young Adult Patients with Relapsed/Refractory Solid Tumors (iMATRIX Idasa): Results of a Ph...Alba Rubio-San-Simón, Lynley V Marshall, Francois Doz, Jaume Mora, Kevin Bielamowicz
Targeted Oncology. 2026-01-01 - Central Nervous System Kinase-Altered Spindle Cell Neoplasm: A Case Series of an Emerging Tumour Type.Faizan Malik, Julieann C Lee, Soniya Pinto, Maria Cardenas, Melanie Hakar
Neuropathology and Applied Neurobiology. 2025-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
